Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate With the Metabolic Syndrome

NCT00632840 is registered in ClinicalTrials.gov with The University of Western Australia as lead sponsor.

NCT NCT00632840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate With the Metabolic Syndrome
Lead sponsor
The University of Western Australia
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2001
Completion date
December 31, 2007
Enrollment
11 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, hypertriglyceridemia, lipid disorders, obesity